We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Iq-ai Limited | LSE:IQAI | London | Ordinary Share | JE00BD4H0R42 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.60 | 1.50 | 1.70 | 1.60 | 1.55 | 1.60 | 326,452 | 14:24:11 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Florists | 609k | -624k | -0.0028 | -5.71 | 3.55M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/10/2023 11:30 | I agree F there needs to be a cross section of views posted to encourage debate. Many of us hold and trade the same stock but that does not prevent us from being negative or positive as the case maybe at any given time, or question RNS etc. | clocktower | |
27/10/2023 11:03 | Only two MM on offer at 4.4p | clocktower | |
27/10/2023 11:02 | Clearly most followers of this stock must be posting on other sites these days, I say that because of the amount of support there has been over the last couple of months there has been very few serious PI's that have posted on either thread. | clocktower | |
27/10/2023 10:58 | you get the feeling that one revenue generating RNS and the share price will fly | howdlep | |
27/10/2023 10:18 | The bid is 500,000 for 4.125p | festario | |
27/10/2023 10:16 | Oh, there's my answer. None left at 4.4p | festario | |
27/10/2023 10:05 | Anyone got level 2, so we can see how many are left on the offer at the 4.3p level? | festario | |
27/10/2023 07:44 | Yes, thanks for the post howdlep, a very good post and there is a great level of support, so it should go places but still worth trying to ride the waves, so far so good but unless there was really outstanding news 5p is my target this time. Still a great long term hold if even you want to put a couple of thousand pounds worth in the portfolio impo. | clocktower | |
27/10/2023 06:53 | I really appreciate you posting that, it does help to make us understand what is happening and what it hopefully is leading to. I can't use LSE, but maybe I should give it another whirl? | festario | |
26/10/2023 13:26 | 500k for 4.04p Or 3.8p for a million | festario | |
26/10/2023 11:41 | I'm bid 4.04p now for 500,000 shares | festario | |
26/10/2023 08:36 | Yes, it's 4.02p to sell 250,000 | festario | |
26/10/2023 08:27 | Never completely out F but I add as and when, and the other day I said I thought it offered value. :-) Looking good again today. | clocktower | |
25/10/2023 23:41 | Thanks spurs, getting interesting. Thought the review would take longer to start. They can apply for their $100M voucher in less than 60 days then as its once the process starts not once they get a decision. "In addition, the FDA recently granted orphan drug designation (ODD) status for GaM in the treatment of another rare cancer, atypical teratoid rhabdoid tumor (ATRT), which was based on yet another pre-clinical study conducted in the Schmainda lab at MCW. This is the second ODD for GaM this year. We are currently working on an application for FDA Fast Track Designation. This is a program the FDA uses to fosters accelerated development and review of drugs that treat conditions with an unmet clinical need. We are targeting a submission by the end of October. Once that submission is under review, and to leverage our ODD designation for pediatric brain tumors (GBM and ATRT), we will apply for a Rare Pediatric Disease Priority Review Voucher (RPD-PRV). Like the Fast Track program, RPD-PRV is another accelerated pathway authorised by the FDA which offers incentives for development and approval for promising drugs. If IB is successful in applying for an RPD-PRV, the vouchers can be transferred (sold) to other companies and the trading price of a PRV, per KIDS V CANCER (givekidsachanceact. | bad gateway | |
25/10/2023 19:34 | IQAI TWEET! Another step forward in bringing innovative therapies to patients with #GBM - we submitted a Fast Track designation request to the FDA for oral gallium maltolate. Fast Track is an expedited approval pathway for agents that treat serious conditions & address unmet clinical needs. How long is Fast Track FDA approval? within sixty days Fast Track designation must be requested by the drug company. The request can be initiated at any time during the drug development process. FDA will review the request and make a decision within sixty days based on whether the drug fills an unmet medical need in a serious condition. Not long to wait! | spurs90 | |
25/10/2023 12:25 | Now its 3.99p for 500,000 shares Or 3.82p for 800,000 | festario | |
25/10/2023 10:23 | Are you back in Clockster? It never reached your 3p, but you could have grabbed 3.5p at best. | festario | |
25/10/2023 10:18 | Solid move up again, maybe hit 5p again. | clocktower | |
25/10/2023 09:56 | Price to sell 500k shares is 3.99p A very nice platform for another move up. | festario | |
24/10/2023 12:51 | Are you saying the 560k is yours clocky? | spurs90 | |
24/10/2023 12:45 | Some value around today here I noticed. | clocktower |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions